157 related articles for article (PubMed ID: 24178704)
1. Efficacy of infliximab in neuro-Behçet's disease presenting with isolated longitudinally extensive transverse myelitis.
Kuroda R; Suzuki J; Muramatsu M; Tasaki A; Yano M; Imai N; Serizawa M; Kobari M
J Neurol; 2013 Dec; 260(12):3167-70. PubMed ID: 24178704
[No Abstract] [Full Text] [Related]
2. Longitudinally extensive transverse myelitis as the sole presentation of neuro-Behçet's disease responding to infliximab.
Coulter I; Huda S; Baborie A; Jacob A
J Spinal Cord Med; 2012 Mar; 35(2):122-4. PubMed ID: 22333754
[TBL] [Abstract][Full Text] [Related]
3. Recurrent longitudinal extensive transverse myelitis in a neuro-Behçet syndrome treated with infliximab.
Uygunoğlu U; Pasha M; Saip S; Siva A
J Spinal Cord Med; 2015 Jan; 38(1):111-4. PubMed ID: 24673549
[TBL] [Abstract][Full Text] [Related]
4. Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years.
Kanemaru H; Makino T; Jinnin M; Yonemitsu A; Makino K; Ihn H
J Dermatol; 2013 Aug; 40(8):632-4. PubMed ID: 23724912
[TBL] [Abstract][Full Text] [Related]
5. Infliximab monotherapy for neuro-Behçet's disease: a case report.
Di Filippo M; Di Gregorio M; Nannini C; Gaetani L; Gallina C; Floridi P; Sarchielli P; Calabresi P; Cantini F
J Neurol Sci; 2014 Dec; 347(1-2):389-90. PubMed ID: 25456463
[No Abstract] [Full Text] [Related]
6. [Behcet's refractory uveitis treated successfully by infliximab].
Mahfoudhi M; Hariz A; Ben Abdelghani K; Turki S; Kheder A
Tunis Med; 2014 Jan; 92(1):41-2. PubMed ID: 24879172
[No Abstract] [Full Text] [Related]
7. Cryptococcal meningitis in a patient treated with infliximab and mycophenolate mofetil for Behcet's disease.
Kluger N; Poirier P; Guilpain P; Baixench MT; Cohen P; Paugam A
Int J Infect Dis; 2009 Sep; 13(5):e325. PubMed ID: 19157948
[No Abstract] [Full Text] [Related]
8. Spinal cord involvement in Behçet's disease.
Lee HS; Kim do Y; Shin HY; Choi YC; Kim SM
Mult Scler; 2016 Jun; 22(7):960-3. PubMed ID: 26480923
[TBL] [Abstract][Full Text] [Related]
9. Transverse myelitis in a patient with Behcet's disease: favorable outcome with a combination of interferon-alpha.
Calgüneri M; Onat AM; Oztürk MA; Ozçakar L; Ureten K; Akdogan A; Ertenli I; Kiraz S
Clin Rheumatol; 2005 Feb; 24(1):64-6. PubMed ID: 15517447
[TBL] [Abstract][Full Text] [Related]
10. Mimicry between intestinal Behçet's disease and inflammatory bowel disease.
Rodrigues-Pinto E; Magro F; Pimenta S; Guimarães J; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):714-5. PubMed ID: 24389388
[No Abstract] [Full Text] [Related]
11. Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum.
Al Sawaf A; Berger JR
Mult Scler Relat Disord; 2015 Sep; 4(5):395-399. PubMed ID: 26346785
[TBL] [Abstract][Full Text] [Related]
12. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
Morris DS; Gavin MP; Sturrock RD
Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
[No Abstract] [Full Text] [Related]
13. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
[No Abstract] [Full Text] [Related]
14. [Acute transverse myelitis revealing neurobehçet disease].
Albakaye M; Zahlan S; Louhab N; Adali N; Kissani N
Rev Neurol (Paris); 2014 Feb; 170(2):144-6. PubMed ID: 24412410
[No Abstract] [Full Text] [Related]
15. Psoriasis triggered by infliximab in a patient with Behçet's disease.
Kawazoe Y; Sugita S; Yamada Y; Akino A; Miura K; Mochizuki M
Jpn J Ophthalmol; 2013 Jan; 57(1):95-7. PubMed ID: 23090423
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report.
Li Y; Han Z; Wang X; Mo Z; Zhang W; Li A; Liu S
BMC Gastroenterol; 2013 Dec; 13():167. PubMed ID: 24321021
[TBL] [Abstract][Full Text] [Related]
17. Regression of severe Behcet's eye disease with infliximab therapy; .first two cases treated in Pakistan.
Ishaq S; Saeed A; Jawad M
J Pak Med Assoc; 2012 Nov; 62(11):1242-4. PubMed ID: 23866421
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.
Leccese P; Latanza L; D'Angelo S; Padula A; Olivieri I
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S93. PubMed ID: 21813069
[No Abstract] [Full Text] [Related]
19. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
[TBL] [Abstract][Full Text] [Related]
20. Successful use of infliximab in a patient with neuro-Behçet's disease.
Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
